Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis.
Adolescent
Adult
Black or African American
/ statistics & numerical data
Birth Weight
Case-Control Studies
Causality
Central Nervous System Neoplasms
/ diagnosis
Cesarean Section
Child
Child, Preschool
Female
Follow-Up Studies
Gestational Age
Hispanic or Latino
/ statistics & numerical data
Humans
Infant
Infant, Newborn
Male
Mothers
/ statistics & numerical data
Pregnancy
Premature Birth
/ epidemiology
Prenatal Exposure Delayed Effects
/ diagnosis
Risk Factors
Survival Analysis
White People
/ statistics & numerical data
Young Adult
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 05 2021
17 05 2021
Historique:
received:
20
10
2020
accepted:
06
04
2021
entrez:
18
5
2021
pubmed:
19
5
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Central nervous system (CNS) tumors are the most common solid tumors in children. Findings on the role of maternal and perinatal factors on the susceptibility or outcome of these tumors are inconclusive. Therefore, we investigated the association between these early-life factors, risk, and survival of pediatric CNS tumors, using data from one of the world's largest and most diverse cancer registries. Information on pediatric CNS tumor cases (n = 1950) for the period 1995-2011 was obtained from the Texas Cancer Registry. Birth certificate controls were frequency-matched on birth year at a ratio of 10:1 for the same period. Evaluated maternal and perinatal variables were obtained from birth records. Unconditional logistic regression was used to generate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for etiological factors. Additionally, Cox proportional hazards regression was employed to assess adjusted hazard ratios (HRs) and 95% CIs for survival factors. The results indicated that Hispanic and non-Hispanic black mothers were less likely to have children with CNS tumors compared to non-Hispanic white mothers (OR 0.88 [95% CI 0.78-0.98] P-value = 0.019; OR 0.79 [95% CI 0.67-0.93 P-value = 0.004], respectively). Infants born large for gestational age (OR 1.26 [95% CI 1.07-1.47] P-value = 0.004) and those delivered pre-term (OR 1.19 [95% CI 1.04-1.38] P-value = 0.013) showed an increased risk of CNS tumors. Infants born by vaginal forceps or vacuum delivery had a higher risk of CNS tumors compared to those born by spontaneous vaginal delivery (OR 1.35 [95% CI 1.12-1.62] P-value = 0.002). Additionally, offspring of Hispanic and non-Hispanic black mothers showed a higher risk of death (HR 1.45 [95% CI 1.16-1.80] P-value = 0.001; HR 1.53 [95% CI 1.12-2.09] P-value = 0.008, respectively). Infants born by cesarean had a higher risk of death compared to those delivered vaginally (HR 1.28 [95% CI 1.05-1.57] P-value = 0.016). These findings indicate the important role of maternal and perinatal characteristics in the etiology and survival of these clinically significant malignancies.
Identifiants
pubmed: 34001927
doi: 10.1038/s41598-021-88385-3
pii: 10.1038/s41598-021-88385-3
pmc: PMC8129132
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10410Références
J Neurosurg Pediatr. 2016 Nov;18(5):585-593
pubmed: 27540957
Front Oncol. 2014 Mar 24;4:47
pubmed: 24716189
J Neurooncol. 2009 May;93(1):25-39
pubmed: 19430880
Pediatr Blood Cancer. 2019 Feb;66(2):e27501
pubmed: 30350913
Epidemiology. 1996 Sep;7(5):485-9
pubmed: 8862978
Cancer Epidemiol. 2016 Feb;40:52-9
pubmed: 26625087
Neuro Oncol. 2015 Jan;16 Suppl 10:x1-x36
pubmed: 25542864
J Neurooncol. 2018 May;138(1):83-97
pubmed: 29417400
Neuro Oncol. 2019 Nov 4;21(11):1357-1375
pubmed: 31301133
Neurosurgery. 2010 Mar;66(3):427-37; discussion 437-8
pubmed: 20124933
Nat Rev Neurol. 2011 Jul 26;7(9):495-506
pubmed: 21788981
J Neurotrauma. 2012 May 1;29(7):1328-33
pubmed: 22320191
Cancer Epidemiol. 2019 Apr;59:178-184
pubmed: 30818125
Acta Paediatr. 2009 Jul;98(7):1096-9
pubmed: 19638013
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36
pubmed: 25192704
Cancer. 2005 Apr 1;103(7):1457-67
pubmed: 15712273
PLoS One. 2011;6(9):e25254
pubmed: 21980406
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100
pubmed: 31675094
BMC Pregnancy Childbirth. 2014 Jan 20;14:36
pubmed: 24444326
N Engl J Med. 1999 Dec 2;341(23):1709-14
pubmed: 10580069
J Pediatr. 2018 Jun;197:292-296.e3
pubmed: 29398059
Clin Cancer Res. 2002 Jun;8(6):1822-30
pubmed: 12060623
Curr Opin Pediatr. 2018 Feb;30(1):3-9
pubmed: 29315108
J Racial Ethn Health Disparities. 2018 Oct;5(5):1131-1141
pubmed: 29516435
Lancet Haematol. 2016 Apr;3(4):e176-85
pubmed: 27063976
Acta Paediatr. 2011 Dec;100(12):1518-22
pubmed: 21950660
Am J Epidemiol. 2018 May 1;187(5):982-991
pubmed: 29036606
Eur J Cancer. 2006 May;42(7):917-21
pubmed: 16517153
Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):813-821
pubmed: 33653816